HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Ltd
Previous close
$17.61
Day range
$17.45 - $18.05
Year range
$10.65 - $22.09
Market cap
1.26B USD
Avg Volume
380.54K
P/E ratio
209.86
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 79.86M | 65.18% |
Operating expense | 65.02M | 47.04% |
Net income | -17.70M | -44.29% |
Net profit margin | -22.17 | 12.65% |
Earnings per share | -0.25 | -38.89% |
EBITDA | -15.96M | -50.54% |
Effective tax rate | -24.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 206.37M | 10.07% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 438.84M | — |
Shares outstanding | 70.62M | — |
Price to book | 2.83 | — |
Return on assets | — | — |
Return on capital | -9.17% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.70M | -44.29% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2015
Website
Employees
297